Sudden Weakness in the Legs or Difficulty Walking During Immunotherapy — Treat It as a Neurological Emergency
Sudden weakness in the legs or new difficulty walking during immunotherapy can be an immune-related nerve or muscle reaction — sometimes similar to Guillain-Barré syndrome — that can worsen within hours and, in rare cases, affect breathing or heart muscle. Oncology guidance on immune-related adverse events treats this combination as a neurological emergency needing same-day, often same-hour, assessment.
Medically reviewed by Dr. T. Raghavender Reddy, Medical Oncologist, MBBS · DM (Medical Oncology) · MD (Radiation Oncology) · Last reviewed August 2026
- It can escalate fast — weakness that spreads upward from the legs can affect breathing muscles within hours if it isn't treated.
- Not something to wait out — new or spreading leg weakness needs same-day, sometimes same-hour, assessment, not a scheduled appointment.
- It isn't always "just" the nerves — related muscle and heart inflammation can occur together, so chest pain or palpitations alongside weakness matter too.
- Treatable when caught early — steroids, IV immunoglobulin and close monitoring can stop or reverse this reaction when started promptly.
on Panel
Survival Rate*
Treated
(800+ reviews)
New or Worsening Leg Weakness on Immunotherapy Needs Emergency Care Now
Sudden weakness in the legs or new difficulty walking during immunotherapy can be an immune-related nerve or muscle reaction that can spread and worsen within hours. It is not something to monitor at home — treat any new or spreading weakness as a neurological emergency needing immediate assessment, especially if it comes with breathing difficulty, swallowing trouble, chest pain or an irregular heartbeat.
Call now, or go to the nearest emergency room, if you have:
- Weakness in the legs that is new, sudden, or spreading upward toward the arms, chest or throat
- Difficulty walking or standing, or a leg that suddenly gives way
- Drooping eyelids, double vision, or difficulty swallowing or speaking alongside the weakness
- Breathlessness, chest pain, palpitations or an irregular heartbeat with the weakness
- Weakness in both legs, or weakness that is getting worse over hours rather than improving
What Could Be Causing Sudden Leg Weakness on Immunotherapy?
Sudden leg weakness during immunotherapy usually points to one of a small number of immune-related nerve or muscle reactions, or, less often, an unrelated cause such as a spinal or metabolic problem. A neurological and cardiac examination, blood tests and, where needed, nerve or muscle studies are what actually identify the cause — not the pattern of symptoms alone.
| Possible cause | Typical pattern | Key distinguishing clue |
|---|---|---|
| Immune-related neuropathy (Guillain-Barré-like) | Weakness starting in the feet or legs, may spread upward; sometimes tingling or numbness | Nerve conduction studies show slowed nerve signals; often improves with IVIG or steroids |
| Immune-related myositis (muscle inflammation) | Weakness with muscle aches or tenderness; may affect the neck or swallowing muscles | Raised creatine kinase (CK) on a blood test; confirmed with muscle MRI or biopsy |
| Myasthenia gravis-like reaction | Weakness that worsens with activity and improves with rest; drooping eyelids, double vision | Symptoms fluctuate through the day; specific antibody and nerve-conduction tests confirm it |
| Overlap with immune-related myocarditis | Weakness together with chest pain, palpitations or breathlessness | Raised cardiac troponin, ECG or echocardiogram changes — treated as a cardiac emergency too |
How Fast Does This Kind of Weakness Usually Progress?
Immune-related nerve and muscle reactions can move quickly once they start, which is the main reason they are treated as emergencies rather than watched. Reporting weakness the same day it starts gives your care team the best chance of stopping it before it spreads further.
| Stage | What's typically happening |
|---|---|
| Typically starts | Immune-related nerve or muscle weakness most often appears within the first few months of starting immunotherapy, though it can occur at any point during treatment and, less commonly, weeks after stopping. |
| Early phase | Mild weakness or heaviness in one or both legs, sometimes with tingling, cramping or unsteady walking — easy to mistake for tiredness or a strained muscle. |
| If untreated | Weakness can spread upward from the legs toward the arms, chest and throat muscles within hours to a few days, potentially affecting breathing and swallowing. |
Because the underlying cause changes what treatment is needed — steroids, IVIG, plasma exchange, or urgent cardiac care — the priority is getting assessed quickly, not trying to identify the cause yourself.
Where Should You Go If You Have Sudden Leg Weakness on Immunotherapy?
Call your oncology team's helpline first if you have one, or go directly to the nearest emergency room — do not wait to be seen at a routine clinic visit. Tell the treating doctors clearly that you are on immunotherapy, since this changes how the weakness is investigated and treated, and mention any chest pain, palpitations or breathlessness alongside the weakness without downplaying it.
If weakness is spreading upward, or you have breathing or swallowing difficulty, call emergency services rather than arranging your own transport to hospital.
CION cancer care is closer than you think.
We're never more than 30 minutes away. Same panel of specialists at every centre. Same tumour board reviews. Same NCCN protocols. Pick the closest one and call directly — or let us pick for you.
Not sure which centre fits best? Tell us where you are — we'll suggest the closest one with the right specialists.
Help me pick the right centre35+ centres across Telangana & Andhra Pradesh
Travelling for treatment? We may have a centre right where you are.
Don't see your city? Call 18002028726 — we'll find your nearest CION partner centre.
17+ senior cancer specialists. One panel for your case.
Trained at AIIMS, Tata Memorial, and leading international centres. Combined 150+ years of experience. Every complex case is reviewed by 3+ of them — together.
Dr. C. Raghavendra Reddy
MBBS(Gold Medal), DNB(General Medicine), DM(Medical Oncology)(Gold Medal)
Dr. Bharati Devi Gorantla
MBBS, MD(General Medicine), DM(Medical Oncology)(Adyar,Chennai), ECMO, MRCP SCE(UK)
Dr. Owais Mohammed
MBBS, MD (General Medicine), DrNB (Medical Oncology), ECMO, MRCP SCE (Medical Oncology) (UK)
Dr. Muralidhar Muddusetty
MBBS (AIIMS), MS (Surgery) (AIIMS), DNB (Surgical Oncology), MRCS (Edinburgh)
Dr. Vinay Mamidala
MBBS, MS(General Surgery), M.Ch(Surgical Oncology), FMAS, FARIS(Ongoing)
Dr. Mohammed Imran
Dr. Vajja Sandeep Kumar
MBBS, MS (General Surgery), DrNB (Surgical Oncology), FALS Oncology
Want a specific doctor for your case? Mention them when booking.
Book Free ConsultationBook an appointment with our specialist
Share your name and number — we'll call you back within 30 minutes to schedule your consultation.
Don't Wait Out Sudden Leg Weakness on Immunotherapy
Our tumour board includes the same specialists managing your immunotherapy — reach them directly.
How Is the Cause of Sudden Leg Weakness Actually Confirmed?
Reporting weakness early leads to a structured pathway, not guesswork — nerve, muscle and heart involvement are all checked together, and treatment starts based on what's actually found. Because immune-related reactions can occur together, an oncology team assessing leg weakness works alongside neurology and, where needed, cardiology from the first visit.
- 1
Immediate neurological and cardiac screening
Your clinician checks muscle strength, reflexes and sensation, and screens for chest pain, palpitations or breathing changes that could point to heart involvement.
- 2
Nerve conduction studies and EMG
These tests measure how well signals travel along the nerves and into the muscles, helping tell a nerve-related reaction apart from a muscle-related one.
- 3
Blood tests, including CK and cardiac troponin
Creatine kinase (CK) checks for muscle inflammation, while cardiac troponin and an ECG or echocardiogram rule out concurrent immune-related heart inflammation.
- 4
Imaging if compression is suspected
An MRI of the spine may be done if there is any possibility the weakness is coming from pressure on the spinal cord rather than an immune reaction.
- 5
Treatment and a decision on your immunotherapy plan
Depending on the cause, treatment may include high-dose steroids, IV immunoglobulin (IVIG) or plasma exchange, alongside a temporary pause in immunotherapy while a multidisciplinary team decides on next steps.
Immune Reactions Are Manageable When Caught Early
Patients who report new weakness promptly are supported by the same multidisciplinary team throughout treatment.
15,000+ patients chose CION. Hear from them directly.
These aren't paid endorsements or written reviews. These are video testimonials from real patients and families — recorded on their own phones, in their own words. Pick any one. Watch it. Then decide.
Read all 800+ reviews on Google
Start Your Story. Book Free Consultation.Sudden Leg Weakness on Immunotherapy: Your Questions Answered
What could sudden leg weakness during immunotherapy mean?
Sudden weakness in the legs or new difficulty walking during immunotherapy can point to an immune-related nerve reaction similar to Guillain-Barré syndrome, immune-related muscle inflammation (myositis), or, less often, a myasthenia gravis-like reaction affecting nerve-to-muscle signalling. Because these reactions can worsen quickly and some overlap with immune-related heart inflammation (myocarditis), any new or spreading weakness during immunotherapy needs same-day neurological and cardiac assessment rather than being put down to tiredness or a pinched nerve.
How fast do I need to act if my legs suddenly feel weak on immunotherapy?
Treat sudden or spreading leg weakness on immunotherapy as an emergency, not a symptom to monitor at home. Immune-related nerve reactions can move from mild leg weakness to weakness affecting breathing muscles within hours to a few days, which is why oncology guidance calls for same-day — often same-hour — assessment. Call your care team's helpline immediately or go straight to the nearest emergency room; do not wait for your next scheduled appointment.
Where should I go if I have sudden leg weakness on immunotherapy?
Call your oncology team's helpline first if you have one, or go directly to the nearest emergency room — do not wait to be seen at a routine clinic visit. Tell the treating doctors clearly that you are on immunotherapy, since this changes how the weakness is investigated and treated. If the weakness is spreading upward, or you have any breathing or swallowing difficulty, call emergency services rather than arranging your own transport.
What is Guillain-Barré-like syndrome from immunotherapy?
Guillain-Barré-like syndrome is an immune-related nerve reaction in which the immune system, over-activated by immunotherapy, attacks the peripheral nerves that control movement and sensation. It typically causes weakness that starts in the legs and can spread upward, sometimes with tingling or numbness. It is treated with high-dose steroids, intravenous immunoglobulin (IVIG) or plasma exchange, and usually needs immunotherapy to be paused while it is investigated and treated.
Can sudden leg weakness be related to my heart, not just my nerves?
Yes. Immune-related muscle inflammation (myositis) and immune-related heart inflammation (myocarditis) are recognised to occur together more often than by chance, so doctors evaluating new leg weakness on immunotherapy routinely also check for chest pain, palpitations, breathlessness or an irregular heartbeat. If any of these accompany your weakness, mention them immediately — they change how urgently, and how, the reaction is treated.
Will I need to stop immunotherapy if this happens?
In most cases, immunotherapy is paused while nerve or muscle-related weakness is investigated and treated, and the decision to restart is made by your oncology team once the reaction has resolved or stabilised on treatment such as steroids. This is a standard, protective step rather than a sign your cancer treatment has failed — many patients are able to safely resume immunotherapy afterwards, guided by how the reaction responded and the wider risks and benefits for your specific cancer.